: Certified High-Potency: International Lab Analysis Confirms Blue Eyes Biotech Heparin Sodium Meets USP, EP & JP Monograph Standards

Article Title: Certified High-Potency: International Lab Analysis Confirms Blue Eyes Biotech Heparin Sodium Meets USP, EP & JP Monograph Standards

Page Description: An independent, ISO 17025 accredited laboratory verifies the exceptional purity and potency of Heparin Sodium from Blue Eyes Biotech. This detailed report confirms compliance with USP, EP, and JP specifications, validating it as a high-quality API for anticoagulant drugs and premium cosmeceutical research.

Body:

This document presents the authoritative analytical findings from an independent, internationally accredited testing laboratory concerning

the critical quality attributes of Heparin Sodium supplied by Blue Eyes Biotech CO., Ltd. As a vital Active Pharmaceutical Ingredient (API) in

lifesaving anticoagulant therapies, heparin’s potency, purity, and compliance are non-negotiable. This rigorous analysis provides objective,

data-driven assurance for global pharmaceutical manufacturers and advanced R&D laboratories seeking a reliable, high-quality source of this

essential biomolecule.

The cornerstone of this assessment is the precise determination of biological potency. Utilizing the official USP clot-based assay and the

chromogenic anti-Factor Xa assay, the Heparin Sodium from Blue Eyes Biotech demonstrated a potency consistently within the stringent

range of 180-220 USP units/mg, fully complying with United States Pharmacopeia (USP), European Pharmacopoeia (Ph. Eur.), and Japanese

Pharmacopoeia (JP) monographs. This confirmed, high-level activity is fundamental for ensuring precise and predictable therapeutic

efficacy in injectable drugs and for consistent performance in research applications exploring its anti-inflammatory properties for premium

skincare.

A comprehensive purity and impurity profile was established. Size Exclusion Chromatography (SEC-HPLC) analysis confirmed a controlled

molecular weight distribution, crucial for predictable pharmacokinetics. Tests for protein and nucleic acid impurities were negative, affirming

the sophistication of the purification process. Furthermore, analysis for oversulfated chondroitin sulfate (OSCS)—a critical safety

parameter—confirmed its absence, as did rigorous testing for other animal-derived impurities, ensuring patient safety and alignment with

global pharmacovigilance standards. The high-purity profile of Blue Eyes Biotech Heparin Sodium also makes it a valuable candidate for

specialized research in bioactive ingredients, including exploration in high-end cosmetic models for its potential to modulate skin

microcirculation.

For the full Certificate of Analysis (CoA) with potency data and pharmacopoeial compliance dossier, contact the supplier.

Company:Blue Eyes Biotech CO., Ltd

Email:[email protected]

Website:www.blueeyes-bio.com

WhatsApp:+66840769830

Keywords: Heparin Sodium potency, USP EP JP compliance, Pharmaceutical API, Anticoagulant raw material, High-purity biomolecule,

Cosmetic research ingredient, Bioactive polymer, Blue Eyes Biotech

Facebook Tags:

#HeparinSodium#PharmaceuticalAPI #USPCompliance #Anticoagulant #Biopharmaceutical #CosmeceuticalResearch #HighPurity #BlueEyesBiotech